During the past decade, Male Health Centre/CMX Research Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Male Health Centre/CMX Research Inc." #1 collaborator was "NCIC Clinical Trials Group" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Male Health Centre/CMX Research Inc." are "Colorectal Cancer" (1 trials), "Melanoma (Skin)" (1 trials), "Multiple Myeloma and Plasma Cell Neoplasm" (1 trials), "Ovarian Cancer" (1 trials) and "Sarcoma" (1 trials). Many other conditions were trialed in "Male Health Centre/CMX Research Inc." in a lesser frequency.

Most popular intervention types in "Male Health Centre/CMX Research Inc." are "Drug" (4 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "alvocidib" (2 trials), "DNA stability analysis" (1 trials), "carboplatin" (1 trials), "gemcitabine hydrochloride" (1 trials) and "gene mapping" (1 trials). Other intervention names were less common.

The vast majority of trials in "Male Health Centre/CMX Research Inc." are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Male Health Centre/CMX Research Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Male Health Centre/CMX Research Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Male Health Centre/CMX Research Inc., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".